Studies reported that TOPK could activate NF-κB in HeLa cells [43] and reduction of NF-κB activity could reverse TMZ resistance by MGMT expression in glioma cells [44], which implied that TOPK could promote MGMT expression through activation of NF-κB to lead to TMZ resistance. This evidence concerns the gene PBK and central nervous system cancer.